Oncology & Cancer

FDA approves drug for PET imaging of prostate cancer

(HealthDay)—The U.S. Food and Drug Administration approved the first drug for positron emission tomography (PET) imaging of prostate-specific membrane antigen (PSMA)-positive lesions in men with prostate cancer, the agency ...

Neuroscience

Assessing state of the art in AI for brain disease treatment

Artificial intelligence is lauded for its ability to solve problems humans cannot, thanks to novel computing architectures that process large amounts of complex data quickly. As a result, AI methods, such as machine learning, ...

Radiology & Imaging

PET/MRI improves lesion detection, reduces radiation exposure

A single-center observational study of more than 1,000 oncological examinations has demonstrated that positron emission tomography/magnetic resonance imaging (PET/MRI) facilitates cancer staging as well as PET/computed tomography ...

Neuroscience

Imagery reveals autism-related brain differences

People with autism spectrum disorder have lower levels of a protein that regulates the amount of serotonin in the brain, a paper from Karolinska Institutet in Sweden published in the journal Molecular Psychiatry reports. ...

page 1 from 28